JPH03111053A - Medical container - Google Patents
Medical containerInfo
- Publication number
- JPH03111053A JPH03111053A JP1249876A JP24987689A JPH03111053A JP H03111053 A JPH03111053 A JP H03111053A JP 1249876 A JP1249876 A JP 1249876A JP 24987689 A JP24987689 A JP 24987689A JP H03111053 A JPH03111053 A JP H03111053A
- Authority
- JP
- Japan
- Prior art keywords
- container
- thin film
- film
- medical container
- medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000010409 thin film Substances 0.000 claims abstract description 28
- 229920003023 plastic Polymers 0.000 claims abstract description 15
- 239000002985 plastic film Substances 0.000 claims abstract description 11
- 239000000853 adhesive Substances 0.000 claims abstract description 8
- 230000001070 adhesive effect Effects 0.000 claims abstract description 8
- 239000012790 adhesive layer Substances 0.000 claims abstract description 7
- 238000010030 laminating Methods 0.000 claims abstract description 5
- 229910052751 metal Inorganic materials 0.000 claims description 24
- 239000002184 metal Substances 0.000 claims description 24
- 239000010408 film Substances 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 19
- -1 polyethylene Polymers 0.000 claims description 8
- 239000004033 plastic Substances 0.000 claims description 7
- 239000010410 layer Substances 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 2
- 229910052782 aluminium Inorganic materials 0.000 claims description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 2
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920003002 synthetic resin Polymers 0.000 claims description 2
- 239000000057 synthetic resin Substances 0.000 claims description 2
- 239000008155 medical solution Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 9
- 230000004888 barrier function Effects 0.000 abstract description 8
- 239000000725 suspension Substances 0.000 abstract description 3
- 239000005001 laminate film Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 description 16
- 229940079593 drug Drugs 0.000 description 16
- 239000000243 solution Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000011888 foil Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229920006255 plastic film Polymers 0.000 description 4
- 238000001802 infusion Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000002542 deteriorative effect Effects 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000035611 feeding Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229920002689 polyvinyl acetate Polymers 0.000 description 2
- 239000011118 polyvinyl acetate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002433 Vinyl chloride-vinyl acetate copolymer Polymers 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〈産業上の利用分野〉
本発明は粉末状の経管栄養剤や輸液剤を収納する容器で
あって、使用時には溶解液あるいは分散液を加えて溶解
あるいは分散することができ、注射器などで吸引して注
射剤として用いたり、更には輸液チューブなどに接続し
て点滴容器として用いることのできる医療用容器に関す
る。[Detailed Description of the Invention] <Industrial Application Field> The present invention is a container for storing powdered tube nutrition and infusion preparations, which can be dissolved or dispersed by adding a solution or a dispersion solution when used. The present invention relates to a medical container that can be used as an injection by suctioning it with a syringe or the like, or can be connected to an infusion tube or the like and used as a drip container.
〈従来の技術〉
従来、経管栄養剤や輸液剤などの薬割において、製造時
には粉末剤であって、使用時に生理食塩水などの液体を
所定量加えて溶解あるいは分散した後、導入用容器に入
れ、経口的にまたは経静脈的に薬剤を投与する方法がし
ばしば採用されている。<Conventional technology> Conventionally, in the preparation of tube feedings, infusions, and other drugs, they are prepared as powders, and when used, they are dissolved or dispersed by adding a predetermined amount of liquid such as physiological saline, and then placed in a container for introduction. A method of administering the drug orally or intravenously is often adopted.
その際、一般に粉末剤の封入されている容器をそのまま
液体との混合容器兼導入用容器として用いる方法と、経
管栄養網の投与によく採用される方法であるが、使用時
粉末剤を別の容器に移し換えて液体で溶解した後、これ
を別の導入用の専用容器に移し換えて使用する方法とが
ある。In this case, two methods are generally used: one is to use the container containing the powder as it is as a mixing container with liquid and an introduction container, and the other is to separate the powder into a container that is often used for tube feeding. There is a method in which the solution is transferred to a container, dissolved in liquid, and then transferred to another container exclusively for introduction.
前者の方法においては、粉末剤を収容する容器の材質と
してガラスまたはプラスチックが用いられているが、ガ
ラス製の容器は、収納された薬剤の品質の安定性は良好
であるが、嵩高で重く、また割れ易いという欠点を有し
ている。一方、プラスチック製の容器は、軟らかくて嵩
張らず、軽くて扱いやすいという長所を有しているため
、これまでも種々の方法が検討されているが（たとえば
特開昭６１−１８２０７６号公報）、プラスチックは根
本的にガスバリアー性が悪く、従って収納された薬剤の
長期保存性が悪いという欠点を有している。そこでガス
バリアー性を良くするために金属箔などを積層したフィ
ルムが採用されることもあるが、金属箔積層フィルムを
用いた容器は不透明で容器内が見えないため、液面の確
認などが出来ないという欠点を有している。In the former method, glass or plastic is used as the material for the container containing the powdered drug, but glass containers have good stability in the quality of the stored drug, but are bulky and heavy. It also has the disadvantage of being easily broken. On the other hand, plastic containers have the advantage of being soft, not bulky, lightweight, and easy to handle, so various methods have been considered (for example, Japanese Patent Application Laid-Open No. 182076/1983). Plastics fundamentally have poor gas barrier properties, and therefore have the disadvantage of poor long-term storage of stored drugs. Therefore, films laminated with metal foil etc. are sometimes used to improve gas barrier properties, but containers using laminated metal foil films are opaque and the inside of the container cannot be seen, making it difficult to check the liquid level. It has the disadvantage that it is not.
また後者の方法においては、粉末剤を収容する容器の材
質は一般に金属箔積層フィルムを用いた容器が採用され
るが、専用容器に移し換える操作が面倒なうえ、衛生上
問題がある。In the latter method, the material of the container containing the powder agent is generally a container made of a metal foil laminated film, but the operation of transferring the powder to a special container is troublesome and there are hygienic problems.
〈発明が解決しようとする課題〉
本発明は上記の事情に鑑みてなされたもので、収納され
た粉末剤を溶解した後これを導入用容器として使用する
タイプの医療用容器を改良した、ガスバリアー性が良く
、かつ使用時の取扱が容易な医療用容器を提供すること
を目的とする。<Problems to be Solved by the Invention> The present invention has been made in view of the above-mentioned circumstances, and is a gas-containing container which is an improved type of medical container in which the stored powder is dissolved and then used as an introduction container. The purpose of the present invention is to provide a medical container that has good barrier properties and is easy to handle during use.
〈課題を解決するための手段〉
本発明は上記のｉｉＮを解決するために、外表面に残存
液量を表示するための目盛りが印刷された透明なプラス
チックフィルムに、特殊な接着層を介して金属薄膜を積
層してなる積層フィルムから形成されてなる袋状容器で
あって、前記金属薄膜は容易に剥離可能であり、前記袋
状容器の上部に吊り下げ用の穴を、下部に薬液導出口を
設けてなる医療用容器を採用している。<Means for Solving the Problems> In order to solve the above-mentioned iiN, the present invention has a transparent plastic film with a scale printed on its outer surface for displaying the amount of remaining liquid, which is bonded to the transparent plastic film through a special adhesive layer. A bag-like container formed from a laminated film formed by laminating a metal thin film, the metal thin film being easily peelable, and having a hole for hanging in the upper part of the bag-like container and a chemical liquid guide in the lower part. A medical container with an outlet is used.
く作用〉
上記の構成によれば、容器の外表面に被覆された金属薄
膜により容器の内部が遮光されるとともに、ガスバリア
ー性も極めて高くなるので、収納された薬剤の保存性は
通常の条件下では問題となることがない。Effect> According to the above structure, the inside of the container is shielded from light by the metal thin film coated on the outer surface of the container, and the gas barrier property is also extremely high, so that the storage life of the stored drug is maintained under normal conditions. There is no problem below.
また、金属薄膜は容易に剥離可能なので、使用時に金属
薄膜を剥離することにより内部が確認できるうえ、容器
を構成するプラスチックフィルムの外表面には目盛りが
印刷されているので、溶解用の所定量の液体を予め計量
する必要がなく、また薬液投与中には液面の変化を定量
的に目視可能である。In addition, since the metal thin film can be easily peeled off, the interior can be checked by peeling off the metal thin film during use.In addition, a scale is printed on the outer surface of the plastic film that makes up the container, so it is possible to measure the predetermined amount for dissolution. There is no need to measure the liquid in advance, and changes in the liquid level can be visually observed quantitatively during drug administration.
〈実施例〉 次に本発明の実施例について図面に基づいて説明する。<Example> Next, embodiments of the present invention will be described based on the drawings.
第１図は本発明の一実施例に係る医療用容器の金属薄膜
を一部剥離した状態を示す平面図であり、第２図は第１
図の医療用容器を構成する積層フィルムの拡大断面図、
第３図は第２図の積層フィルムの金属薄膜層をさらにプ
ラスチックの薄膜で被覆してなる積層フィルムの拡大断
面図である。FIG. 1 is a plan view showing a medical container according to an embodiment of the present invention with a part of the thin metal film peeled off, and FIG.
An enlarged cross-sectional view of the laminated film constituting the medical container shown in Fig.
FIG. 3 is an enlarged sectional view of a laminated film obtained by further covering the metal thin film layer of the laminated film of FIG. 2 with a plastic thin film.
本発明の医療用容器は、第１図に示すように、中央部の
容器本体（１）と、下部の薬液導出口（２）および上部
の吊下用穴（３）とから構成されてなる袋状の容器であ
り、容器本体（１）は透明なプラスチックフィルム（４
）の目盛り（８）印刷面に金属薄膜（６）を積層してな
る積層フィルム（Ｆ）で形成されている。（１０）は液
体注入口である。As shown in FIG. 1, the medical container of the present invention is composed of a container body (1) in the center, a drug solution outlet (2) in the lower part, and a hanging hole (3) in the upper part. It is a bag-shaped container, and the container body (1) is covered with a transparent plastic film (4
) is formed of a laminated film (F) formed by laminating a metal thin film (6) on the printed surface of the scale (8). (10) is a liquid inlet.
容器本体（１）を構成する積層フィルム（Ｆ）は、外表
面に残存液量を表示するための目盛り（８）を印刷した
透明なプラスチックフィルム（４）に、接着層（５）を
介して金属薄膜（６）を積層したものであり、必要なら
ば、第３図に示すように金属薄膜（６１）層の上にさら
にプラスチックの薄膜（７）を積層したものを使用して
もよい、プラスチックフィルム（４）の材質は、ガスバ
リアー性をあまり考慮する必要がなく、透明でありかつ
耐薬品性の良い軟質のプラスチックが、たとえばポリエ
チレンや、ポリプロピレン、ポリエチレンテレフタルー
ト、軟質塩化ビニル樹脂などが好適に使用される。また
、薄膜（７）の材質は、特に限定されないが、一般にポ
リエチレンやポリプロピレンなどが使用される。そして
容器本体（１）の角部分の少なくとも１か所には好まし
くは接着剤の塗布されていない剥離部（９）が形成され
ており、この部分から引き剥がすことにより容易に金属
薄膜を剥離できるようになっている。The laminated film (F) constituting the container body (1) is attached to a transparent plastic film (4) with a scale (8) printed on its outer surface for displaying the amount of remaining liquid via an adhesive layer (5). A thin metal film (6) is laminated, and if necessary, a thin plastic film (7) may be further laminated on the metal thin film (61) layer as shown in FIG. As for the material of the plastic film (4), there is no need to give much consideration to gas barrier properties, and transparent and soft plastics with good chemical resistance can be used, such as polyethylene, polypropylene, polyethylene terephthalate, and soft vinyl chloride resin. is preferably used. Further, the material of the thin film (7) is not particularly limited, but polyethylene, polypropylene, etc. are generally used. At least one corner of the container body (1) is preferably formed with a peeling part (9) to which no adhesive is applied, and the thin metal film can be easily peeled off by peeling from this part. It looks like this.
また、容器の下部は液体を加える時に立てることができ
るように立体的に形成してもよい。Further, the lower part of the container may be formed three-dimensionally so that it can stand up when adding liquid.
接着層（５）は金ＫＴｉ４膜（６）を容易にプラスチッ
クフィルム（４）から剥離できるように接着する部分で
あり、金ｒ！Ａ薄膜にパートコートされた合成樹脂の薄
膜（５１）と接着剤（５２）とからなり（ビール加工と
言われている）、合成樹脂としては基材である透明なプ
ラスチックフィルム（４）との接着強度の小さい、たと
えばポリウレタンやポリ酢酸ビニル、ポリメチルメタク
リレート、ポリアミド、シリコーン樹脂などが好適に使
用しうる。接着剤としては、特に限定するものではない
が、一般に塩化ビニル−酢酸ビニル共重合物、合成ゴム
、天然ゴム、ポリ酢酸ビニル、変性ポリエステル、エポ
キシ、二液性ウレタンなどが使用可能である。また、接
着される金属薄膜としては一般にアルミニウム箔が使用
される。The adhesive layer (5) is a part that adheres the gold KTi4 film (6) so that it can be easily peeled off from the plastic film (4). It consists of a synthetic resin thin film (51) and adhesive (52) that are part-coated on A thin film (this is said to be beer processing). Materials with low adhesive strength, such as polyurethane, polyvinyl acetate, polymethyl methacrylate, polyamide, and silicone resin, can be suitably used. The adhesive is not particularly limited, but generally vinyl chloride-vinyl acetate copolymer, synthetic rubber, natural rubber, polyvinyl acetate, modified polyester, epoxy, two-component urethane, etc. can be used. Furthermore, aluminum foil is generally used as the metal thin film to be bonded.
尚、パートコートのコートパターンとしては第４図（イ
）〜（ハ）に示すようなものがある。また、薬液導出口
（２）および吊下用穴（３）については一般の薬液バッ
グと同様なので説明を省略する。Incidentally, there are coat patterns for the part coat as shown in FIGS. 4(A) to 4(C). Moreover, the chemical solution outlet (2) and the hanging hole (3) are the same as those of a general chemical solution bag, so the explanation thereof will be omitted.
本医療用容器は粉末状の薬剤を収納するためのものであ
るが、液状の薬剤を収納してもよく、薬剤の収納に際し
ては、容器の上部開放部分から薬剤を収納した後、上部
開放部分を溶着して密封するのが一般的であり、またこ
の時に吊下用穴（３）を形成するのが一般的である。This medical container is for storing powdered medicines, but liquid medicines may also be stored.When storing medicines, after storing the medicines from the open top part of the container, It is common to weld and seal it, and at this time it is common to form a hanging hole (3).
使用に際しては、液体注入口（１０）を開封してここか
ら液体を注入して薬剤を溶解した後、液体注入口（１０
）をクランプ（図示していない）などで封鎖しく上部開
放部分に突条とこの突条と嵌合する溝条からなるいわゆ
るラミジップといわれる開閉自在な閉鎖手段を予め設け
た構造に形成してもよい）、薬液導出口（２）に導液針
（図示していない）などを刺通して経管的にあるいは経
静脈的に薬液を投与する。When in use, open the liquid injection port (10), inject liquid from there to dissolve the drug, and then open the liquid injection port (10).
) can be sealed with a clamp (not shown) or the like, and a structure may be formed in which a so-called lamizip, a closing means that can be opened and closed, is pre-installed on the upper open part, and consists of a protrusion and a groove that fits with the protrusion. The drug solution is administered via a tube or intravenously by inserting a liquid introduction needle (not shown) into the drug solution outlet (2).
〈発明の効果〉
以上説明してきたことから明らかなように、本発明の医
療用容器を使用することにより、容器のガスバリアー性
が良いので保存中に薬剤が変質する虞がない、使用時の
取扱が容易である、溶解液を計量せずに導入出来る、薬
液投与中に液面の変化を定量的に目視可能であるなどの
効果を奏することができる。<Effects of the Invention> As is clear from the above explanation, by using the medical container of the present invention, the container has good gas barrier properties, so there is no risk of the drug deteriorating during storage, and there is no risk of the drug deteriorating during use. It is easy to handle, the solution can be introduced without measuring, and changes in the liquid level can be visually observed quantitatively during drug administration.
第１図は本発明の一実施例に係る医療用容器の金属箔を
一部剥離した状態を示す平面図であり、第２図は第１図
の医療用容器を構成する積層フィルムの拡大断面図、第
３図は第２図の積層フィルムの金属薄膜層をさらにプラ
スチックの薄膜で被覆してなる積層フィルムの拡大断面
図である。また、第４図（イ）〜（ハ）は金属薄膜にパ
ートコ−トされるコートパターンの例を示す図である。
く符号の説明〉
１：容器本体
３：吊下用穴
５：接着層
７：）ｌ膜
９：剥離部
５１：薄膜
Ｆ：積層フィルム
２：薬液導出口
４ニブラスチツクフイルム
６．６１：金属薄膜
８：目盛り
ｌＯ：液体注入口
５２：接着剤FIG. 1 is a plan view showing a state in which the metal foil of a medical container according to an embodiment of the present invention is partially peeled off, and FIG. 2 is an enlarged cross-section of a laminated film constituting the medical container of FIG. 1. 3 are enlarged sectional views of a laminated film obtained by further covering the metal thin film layer of the laminated film of FIG. 2 with a plastic thin film. Further, FIGS. 4A to 4C are diagrams showing examples of coating patterns in which a metal thin film is partially coated. Explanation of symbols> 1: Container body 3: Suspension hole 5: Adhesive layer 7: ) l membrane 9: Peeling part 51: Thin film F: Laminated film 2: Chemical solution outlet 4 Niblast film 6. 61: Metal Thin film 8: Scale lO: Liquid inlet 52: Adhesive
Claims (1)
れた透明なプラスチックフィルムに、特殊な接着層を介
して金属薄膜を積層してなる積層フィルムから形成され
てなる袋状容器であって、前記金属薄膜は容易に剥離可
能であり、前記袋状容器の上部に吊り下げ用の穴を、下
部に薬液導出口を設けてなる医療用容器。 ２）接着層が、金属薄膜にパートコートされた合成樹脂
の薄膜と接着剤からなる請求項１記載の医療用容器。 ３）透明なプラスチックがポリエチレン、ポリプロピレ
ン、ポリエチレンテレフタルート、軟質の塩化ビニル樹
脂からなる群から選ばれる少なくとも１つである請求項
１または２に記載の医療用容器。 ４）金属薄膜がアルミニウムから形成されてなる請求項
１〜３のいずれかに記載の医療用容器。 ５）金属薄膜層をさらにプラスチックの薄膜で被覆して
なる請求項１〜４のいずれかに記載の医療用容器。 ６）袋状部分の角部の少なくとも１か所に接着剤を塗布
していない剥離部を設けてなる請求項１〜５のいずれか
に記載の医療用容器。[Claims] 1) It is formed from a laminated film made by laminating a metal thin film through a special adhesive layer on a transparent plastic film with a scale printed on its outer surface for displaying the amount of remaining liquid. 1. A medical container, wherein the metal thin film is easily peelable, and the bag-like container has a hanging hole in the upper part and a medical solution outlet in the lower part. 2) The medical container according to claim 1, wherein the adhesive layer comprises a synthetic resin thin film part-coated on a metal thin film and an adhesive. 3) The medical container according to claim 1 or 2, wherein the transparent plastic is at least one selected from the group consisting of polyethylene, polypropylene, polyethylene terephthalate, and soft vinyl chloride resin. 4) The medical container according to any one of claims 1 to 3, wherein the metal thin film is made of aluminum. 5) The medical container according to any one of claims 1 to 4, wherein the metal thin film layer is further coated with a plastic thin film. 6) The medical container according to any one of claims 1 to 5, wherein the bag-shaped portion has a peeling portion on which no adhesive is applied at at least one corner.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1249876A JPH03111053A (en) | 1989-09-25 | 1989-09-25 | Medical container |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1249876A JPH03111053A (en) | 1989-09-25 | 1989-09-25 | Medical container |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH03111053A true JPH03111053A (en) | 1991-05-10 |
Family
ID=17199511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1249876A Pending JPH03111053A (en) | 1989-09-25 | 1989-09-25 | Medical container |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH03111053A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0524040U (en) * | 1991-03-14 | 1993-03-30 | 東洋製罐株式会社 | Package for administration of enteral nutritional supplement |
| JPH07178149A (en) * | 1993-12-22 | 1995-07-18 | Fuji Seal Co Ltd | Packing bag for chemicals filling bag and method for manufacturing packing bag and packing bag product |
| JP2002085520A (en) * | 2000-06-23 | 2002-03-26 | Nikken Chem Co Ltd | Highly identifiable plastic container for injection medicine |
| WO2004074132A1 (en) * | 2003-02-19 | 2004-09-02 | Teva Pharmaceutical Industries Ltd. | Methods of stabilizing azithromycin during storage by packaging in a gas impermeable container |
| JP2004313761A (en) * | 2003-04-04 | 2004-11-11 | Nipro Corp | Medicine bag |
| JP2006347565A (en) * | 2005-06-14 | 2006-12-28 | Toppan Printing Co Ltd | Laminated packaging material, and bag-like container having spout |
| JP2007007117A (en) * | 2005-06-30 | 2007-01-18 | Ss Pharmaceut Co Ltd | Soft bag for sealing enteral nutrient |
| JP2009119114A (en) * | 2007-11-16 | 2009-06-04 | C I Kasei Co Ltd | Medical agent container and method for producing medical agent container |
| JP2010013188A (en) * | 1998-10-20 | 2010-01-21 | Acs Dobfar Spa | Bag for storing and transporting sterile product in powder form and producing solution of the product therein |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6486972A (en) * | 1987-09-30 | 1989-03-31 | Nippon Zeon Co | Medical container |
-
1989
- 1989-09-25 JP JP1249876A patent/JPH03111053A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6486972A (en) * | 1987-09-30 | 1989-03-31 | Nippon Zeon Co | Medical container |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0524040U (en) * | 1991-03-14 | 1993-03-30 | 東洋製罐株式会社 | Package for administration of enteral nutritional supplement |
| JPH07178149A (en) * | 1993-12-22 | 1995-07-18 | Fuji Seal Co Ltd | Packing bag for chemicals filling bag and method for manufacturing packing bag and packing bag product |
| JP2010013188A (en) * | 1998-10-20 | 2010-01-21 | Acs Dobfar Spa | Bag for storing and transporting sterile product in powder form and producing solution of the product therein |
| JP2002085520A (en) * | 2000-06-23 | 2002-03-26 | Nikken Chem Co Ltd | Highly identifiable plastic container for injection medicine |
| WO2004074132A1 (en) * | 2003-02-19 | 2004-09-02 | Teva Pharmaceutical Industries Ltd. | Methods of stabilizing azithromycin during storage by packaging in a gas impermeable container |
| JP2004313761A (en) * | 2003-04-04 | 2004-11-11 | Nipro Corp | Medicine bag |
| JP4552469B2 (en) * | 2003-04-04 | 2010-09-29 | ニプロ株式会社 | Drug bag |
| JP2006347565A (en) * | 2005-06-14 | 2006-12-28 | Toppan Printing Co Ltd | Laminated packaging material, and bag-like container having spout |
| JP2007007117A (en) * | 2005-06-30 | 2007-01-18 | Ss Pharmaceut Co Ltd | Soft bag for sealing enteral nutrient |
| JP2009119114A (en) * | 2007-11-16 | 2009-06-04 | C I Kasei Co Ltd | Medical agent container and method for producing medical agent container |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003135563A (en) | Small bag-shaped medicine container | |
| JPS60210261A (en) | Drug delivery system | |
| JPS61355A (en) | Container for bicarbonate-containing solution | |
| JPH05212090A (en) | Transfusion container | |
| CA2040411A1 (en) | Medicament container/dispenser assembly | |
| JP2005000677A (en) | Improved container for parenteral fluid | |
| JPS59500451A (en) | liquid storage sac | |
| KR100871204B1 (en) | Medical liquid container and preparation-containing medical liquid container | |
| CA2262473A1 (en) | Means to maintain configuration of flexible medical container | |
| JPH03111053A (en) | Medical container | |
| KR20130028965A (en) | Flexible container for medical use and nutrient supply system using same | |
| EP3287116A1 (en) | Storage bag for infusion bag/bottle, method for using same, and method for manufacturing same | |
| WO2005089697A1 (en) | Enteral nutrition bag | |
| JP2006043061A (en) | Medical multi-chamber container | |
| JP2000070336A (en) | Medicinal liquid storage container and medicinal liquid injecting set using the container | |
| JP2002095721A (en) | Pouch for transfusion and its outlet tool | |
| US4453929A (en) | Activated charcoal package and process | |
| JPS5830058B2 (en) | Container with scale | |
| JP2592416B2 (en) | Medical container | |
| JPH0380024B2 (en) | ||
| JPS6137951B2 (en) | ||
| JPH048910Y2 (en) | ||
| US6544250B1 (en) | Blind clinical trial device | |
| JP3074192U (en) | Infusion bag | |
| JP2710414B2 (en) | Injection solution dissolver |